Annual Meeting

Using bacteria to clean the environment

Núria  Negrão
April 28, 2021

In recent years, concerns have heightened about increasing amounts of drugs in the environment, particularly in water. While the impact of this environmental pollution is not well understood, some evidence indicates that these drugs may be entering the food chain. Researchers  believe that most of the drugs that end up in fresh water first accumulate at wastewater treatment facilities. Therefore, there is a need to eliminate the drugs at these facilities.

Ashley Robinson, a senior biochemistry major at Hamline University who plans to start graduate school in the fall, started doing research in her sophomore year. She is presenting a poster at the 2021 ASBMB Annual Meeting on this topic, the third research project she has worked on with Betsy Martínez–Vaz.

Kathryn Malody
Ashley Robinson works in the biological safety hood at the Martínez–Vaz lab.

The researchers’ goal was to find bacteria that break down metformin, a drug commonly used to treat diabetes in the U.S. and around the world. Little research has been done on the impact of pollution with metformin and its byproduct, guanylurea, which are not fully metabolized by humans and thus are excreted into wastewater systems. “We consider them to be emerging pollutants,” Robinson said.

Ashley Robinson & James Aukema
This graphic represents the topics of Robinson’s research. With increasing prescription of the Type 2 diabetes drug metformin (top), both metformin and its predominant metabolite, guanylurea (bottom), are water pollutants of emerging concern worldwide. The researchers recently isolated a strain of Pseudomonas that can completely degrade guanylurea from a wastewater treatment facility (middle). They identified and characterized a guanylurea-degrading enzyme, guanylurea hydrolase.

Studies have demonstrated the potential for metformin to disrupt some hormones, she explained. The drug  is considered an endocrine disruption agent in some small fishes, and guanylurea has been shown to interfere with the nitrogen cycle in soil. Little is known about its bioaccumulation potential.

“Can these molecules pass up the food chain?” Robinson said. “That is one concern that we have.”

The research team collected samples at a local wastewater treatment facility from several stages of the treatment process. The bacteria in the samples were then grown in the lab under limiting conditions, meaning the bacteria were not given all the nutrients they needed. In this case, their only source of nitrogen was metformin, so most of the bacteria that survived were species that could use metformin as a nitrogen source. The team then used metagenomics to identify the enzymes involved in the breakdown of guanylurea and its transformation product guanidine. They identified three enzymes: guanylurea hydrolase, carboxyguanidine deiminase and allophanate hydrolase.

Robinson and her colleagues are now working to identify the enzyme that breaks down metformin in the initial step that forms guanylurea. They hope the enzymes they find could be used to break down metformin and guanylurea at wastewater treatment facilities, keeping these pollutants out of freshwater systems.


Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Núria  Negrão

Núria Negrão is a medical writer and editor at Cactus Communications.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Liver enzyme holds key to adjusting to high-protein diets
Journal News

Liver enzyme holds key to adjusting to high-protein diets

Jan. 14, 2025

Researchers at the University of Geneva show that glutamate dehydrogenase controls blood alkalinity during fasting.

Adults grow new brain cells
News

Adults grow new brain cells

Jan. 11, 2025

How does the rare birth of these new neurons contribute to cognitive function?

From the journals: JBC
Journal News

From the journals: JBC

Jan. 9, 2025

Histone demethylase inhibited by own sequence. MicroRNA reduces cell cycle–related apoptosis. Multipurpose antibiotic takes on staph infections. Read about recent JBC papers on these topics.

Tiny laboratories that fit in your hand can rapidly identify pathogens using electricity
News

Tiny laboratories that fit in your hand can rapidly identify pathogens using electricity

Jan. 5, 2025

Pathogens have distinct electrical charges, shapes and sizes. Measuring how quickly they move through an electric field can help researchers separate different species in a sample.

Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment
News

Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment

Jan. 4, 2025

This recent study by a team from Bill Sullivan’s lab at the Indiana University School of Medicine was named a Journal of Biological Chemistry Editor’s Pick.

Of genes, chromosomes and oratorios
Profile

Of genes, chromosomes and oratorios

Jan. 1, 2025

Jenny Graves has spent her life mapping genes and comparing genomes. Now she’s created a musical opus about evolution of life on this planet — bringing the same drive and experimentalism she brought to the study of marsupial chromosomes.